Ming Yan - 07 Mar 2022 Form 4 Insider Report for Cytek Biosciences, Inc. (CTKB)

Reporting relationship: Chief Technology Officer, Director
Issuer ticker: CTKB
Reported as of: 07 Mar 2022
Net transaction value: +$25,325
SEC form: 4
Accepted by SEC: 08 Mar 2022, 16:57:15 UTC
Prior SEC filing: 02 Mar 2022
Next SEC filing: 23 Mar 2022
Source filing: View source filing
Reporting owner signature: /s/ Valerie Barnett, Attorney-in-Fact for Ming Yan

Key filing fact

Ming Yan filed Form 4 for Cytek Biosciences, Inc. (CTKB) on 08 Mar 2022.

Key facts

This page summarizes Ming Yan's Form 4 filing for Cytek Biosciences, Inc. (CTKB).
4 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 08 Mar 2022, 16:57.

Change

Previous filing in this sequence was filed on 02 Mar 2022.
Current net transaction value: +$25,325.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CTKB transaction

Common Stock

Options Exercise

Transaction value: $15,614
Shares: +62,456
Change %: +0.77%
Price: $0.2500^*
Shares after: 8,152,248
Date: 07 Mar 2022
Ownership: Direct

CTKB transaction

Common Stock

Options Exercise

Transaction value: $9,711
Shares: +10,555
Change %: +0.13%
Price: $0.9200^*
Shares after: 8,162,803
Date: 07 Mar 2022
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CTKB transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value: $0
Shares: -62,456
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 07 Mar 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 62,456
Exercise price: $0.2500

CTKB transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value: $0
Shares: -10,555
Change %: -40%
Price: $0.000000
Shares after: 16,111
Date: 07 Mar 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 10,555
Exercise price: $0.9200
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The shares subject to the option vest as follows: 25% of the shares subject to the option vests on July 24, 2021; and 1/48th of the shares subject to the option vest monthly thereafter over the following three years.